These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29316839)

  • 1. Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol.
    Ekblad T; Verheugd P; Lindgren AE; Nyman T; Elofsson M; Schüler H
    SLAS Discov; 2018 Apr; 23(4):353-362. PubMed ID: 29316839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PARP14 is a writer, reader, and eraser of mono-ADP-ribosylation.
    Torretta A; Chatzicharalampous C; Ebenwaldner C; Schüler H
    J Biol Chem; 2023 Sep; 299(9):105096. PubMed ID: 37507011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an Inhibitor Screening Assay for Mono-ADP-Ribosyl Hydrolyzing Macrodomains Using AlphaScreen Technology.
    Haikarainen T; Maksimainen MM; Obaji E; Lehtiö L
    SLAS Discov; 2018 Mar; 23(3):255-263. PubMed ID: 29028410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Intracellular Auto-Modification Levels of ARTD10 Using Mono-ADP-Ribose-Specific Macrodomains 2 and 3 of Murine Artd8.
    Bütepage M; Krieg S; Eckei L; Li J; Rossetti G; Verheugd P; Lüscher B
    Methods Mol Biol; 2018; 1813():41-63. PubMed ID: 30097860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation.
    O'Sullivan J; Tedim Ferreira M; Gagné JP; Sharma AK; Hendzel MJ; Masson JY; Poirier GG
    Nat Commun; 2019 Mar; 10(1):1182. PubMed ID: 30862789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARP14 is regulated by the PARP9/DTX3L complex and promotes interferon γ-induced ADP-ribosylation.
    Ribeiro VC; Russo LC; Hoch NC
    EMBO J; 2024 Jul; 43(14):2908-2928. PubMed ID: 38834852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a Selective Allosteric Inhibitor Targeting Macrodomain 2 of Polyadenosine-Diphosphate-Ribose Polymerase 14.
    Schuller M; Riedel K; Gibbs-Seymour I; Uth K; Sieg C; Gehring AP; Ahel I; Bracher F; Kessler BM; Elkins JM; Knapp S
    ACS Chem Biol; 2017 Nov; 12(11):2866-2874. PubMed ID: 28991428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities.
    Đukić N; Strømland Ø; Elsborg JD; Munnur D; Zhu K; Schuller M; Chatrin C; Kar P; Duma L; Suyari O; Rack JGM; Baretić D; Crudgington DRK; Groslambert J; Fowler G; Wijngaarden S; Prokhorova E; Rehwinkel J; Schüler H; Filippov DV; Sanyal S; Ahel D; Nielsen ML; Smith R; Ahel I
    Sci Adv; 2023 Sep; 9(37):eadi2687. PubMed ID: 37703374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCDD-inducible poly-ADP-ribose polymerase (TIPARP/PARP7) mono-ADP-ribosylates and co-activates liver X receptors.
    Bindesbøll C; Tan S; Bott D; Cho T; Tamblyn L; MacPherson L; Grønning-Wang L; Nebb HI; Matthews J
    Biochem J; 2016 Apr; 473(7):899-910. PubMed ID: 26814197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts.
    Daugherty MD; Young JM; Kerns JA; Malik HS
    PLoS Genet; 2014; 10(5):e1004403. PubMed ID: 24875882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conserved macrodomains of the non-structural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADP-ribosylhydrolases.
    Eckei L; Krieg S; Bütepage M; Lehmann A; Gross A; Lippok B; Grimm AR; Kümmerer BM; Rossetti G; Lüscher B; Verheugd P
    Sci Rep; 2017 Feb; 7():41746. PubMed ID: 28150709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.
    Grunewald ME; Chen Y; Kuny C; Maejima T; Lease R; Ferraris D; Aikawa M; Sullivan CS; Perlman S; Fehr AR
    PLoS Pathog; 2019 May; 15(5):e1007756. PubMed ID: 31095648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A macrodomain-linked immunosorbent assay (MLISA) for mono-ADP-ribosyltransferases.
    Chen J; Lam AT; Zhang Y
    Anal Biochem; 2018 Feb; 543():132-139. PubMed ID: 29247608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a novel allosteric inhibitor scaffold for polyadenosine-diphosphate-ribose polymerase 14 (PARP14) macrodomain 2.
    Moustakim M; Riedel K; Schuller M; Gehring AP; Monteiro OP; Martin SP; Fedorov O; Heer J; Dixon DJ; Elkins JM; Knapp S; Bracher F; Brennan PE
    Bioorg Med Chem; 2018 Jul; 26(11):2965-2972. PubMed ID: 29567296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analogs of TIQ-A as inhibitors of human mono-ADP-ribosylating PARPs.
    Maksimainen MM; Murthy S; Sowa ST; Galera-Prat A; Rolina E; Heiskanen JP; Lehtiö L
    Bioorg Med Chem; 2021 Dec; 52():116511. PubMed ID: 34801828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The search for inhibitors of macrodomains for targeting the readers and erasers of mono-ADP-ribosylation.
    Fu W; Yao H; Bütepage M; Zhao Q; Lüscher B; Li J
    Drug Discov Today; 2021 Nov; 26(11):2547-2558. PubMed ID: 34023495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.
    Lu AZ; Abo R; Ren Y; Gui B; Mo JR; Blackwell D; Wigle T; Keilhack H; Niepel M
    Biochem Pharmacol; 2019 Sep; 167():97-106. PubMed ID: 31075269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure and biochemical activity of the macrodomain from rubella virus p150.
    Stoll GA; Nikolopoulos N; Zhai H; Zhang L; Douse CH; Modis Y
    J Virol; 2024 Feb; 98(2):e0177723. PubMed ID: 38289106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight.
    Hopp AK; Hottiger MO
    Cells; 2021 Mar; 10(3):. PubMed ID: 33808662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ENPP1 processes protein ADP-ribosylation in vitro.
    Palazzo L; Daniels CM; Nettleship JE; Rahman N; McPherson RL; Ong SE; Kato K; Nureki O; Leung AK; Ahel I
    FEBS J; 2016 Sep; 283(18):3371-88. PubMed ID: 27406238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.